Non-viral delivery

Non-viral delivery for gene therapy A next generation gene therapy delivery approach The Duchenne Research Fund has committed £640,000 to accelerate research into alternative ways to deliver gene therapy to Duchenne patients, with the aim of increasing the number of...

CRISPR

CRISPR for Duchenne Genome editing technology to correct the mutated dystrophin gene The Duchenne Research Fund has awarded a £200,000 grant to the team at the Hospital for Sick Children in Toronto, Canada (‘Sick Kids’), who are working on using...

GOSH coordinator

Great Ormond Street Hospital Clinical Trial Co-ordinator Manju Agarwal As part of the Newcastle Plan in 2015/16, eight patient organisations contributed £1.2m to fund at least 16 vital posts across the UK to support and expand clinical trial capacity for Duchenne...

HHMI fellowship

HHMI-DRF Fellowship Grant for a medical student researching Duchenne As part of our holistic approach to tackling Duchenne, we aim to nurture young talent in the field of Duchenne research. At the end of 2010, we announced a partnership with the Howard Hughes Medical...

WMS Duchenne Research Prize

Duchenne Research Prize International World Muscle Congress anuual congress Since 2012 we have sponsored the Duchenne Research Prize at the World Muscle Society’s annual international congress. The award recognises the work of a young Duchenne muscular dystrophy...